Luther King Capital Management (LKCM)
JAZZ icon

Luther King Capital Management (LKCM)’s Jazz Pharmaceuticals JAZZ Stock Holding History

Luther King Capital Management (LKCM)’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3,108
Closed -$413K – 540
2015
Q3 		$413K Buy
3,108
+38
+1% +$6.54K ﹤0.01% 436
2015
Q2 		$541K Hold
3,070
– – ﹤0.01% 421
2015
Q1 		$530K Hold
3,070
– – ﹤0.01% 426
2014
Q4 		$503K Buy
+3,070
New +$510K ﹤0.01% 436

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HCM
Herndon Capital Management Atlanta, Georgia $659M AUM 22.02% 1-Year Est. Return

Luther King Capital Management (LKCM)'s JAZZ Position: Q4 2015 in Review

Luther King Capital Management (LKCM) sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2015, closing a stake of 3,108 shares — an estimated $413K sold.

Luther King Capital Management (LKCM) first reported a position in JAZZ in Q4 2014 and held it in 4 quarters. The position peaked at $541K in Q2 2015. 346 funds tracked by Wall St. Rank hold JAZZ as of Q4 2015.

  • Luther King Capital Management (LKCM) reported no remaining Jazz Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Luther King Capital Management (LKCM) sold 3,108 Jazz Pharmaceuticals shares in Q4 2015, an estimated $413K.
  • Luther King Capital Management (LKCM) first reported a position in Jazz Pharmaceuticals in Q4 2014 and held it in 4 quarters.
  • Luther King Capital Management (LKCM)'s Jazz Pharmaceuticals position peaked at $541K in Q2 2015.
  • 346 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2015.

Based on Luther King Capital Management (LKCM)'s 13F filing for Q4 2015, filed 11 Feb 2016.